Page last updated: 2024-08-25

cromakalim and cardiovascular agents

cromakalim has been researched along with cardiovascular agents in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19901 (12.50)18.7374
1990's6 (75.00)18.2507
2000's1 (12.50)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adachi, H; Kodama, K; Ogawa, T; Ohhara, H1
Dzwonczyk, S; Grover, GJ; Sleph, PG1
Coldwell, MC; Cooper, SM; Hamilton, TC; Howlett, DR; Wilson, C1
Challinor-Rogers, JL; Hay, TK; McPherson, GA1
Chiba, S; Furukawa, Y; Inoue, Y; Sawaki, S; Takayama, S1
Brasch, H1
Hosseinzadeh, H; Stone, TW1
Atwal, KS; Bajgar, R; D'Alonzo, AJ; Darbenzio, RB; Garlid, KD; Grover, GJ; Hess, TA; Lodge, NJ; Paucek, P; Sleph, PG; Smith, MA1

Other Studies

8 other study(ies) available for cromakalim and cardiovascular agents

ArticleYear
Inhibitory effect of a novel antianginal agent, E4080, on ST segment elevation induced by vasopressin in anesthetized guinea pigs.
    Japanese journal of pharmacology, 1992, Volume: 60, Issue:2

    Topics: Anesthesia; Animals; Benzopyrans; Cardiovascular Agents; Catechols; Clonidine; Coronary Vessels; Cromakalim; Electrocardiography; Guinea Pigs; Heart Rate; Imidazoles; In Vitro Techniques; Isosorbide Dinitrate; Male; Nifedipine; Pyrroles; Vasodilator Agents; Vasopressins

1992
Pharmacologic profile of cromakalim in the treatment of myocardial ischemia in isolated rat hearts and anesthetized dogs.
    Journal of cardiovascular pharmacology, 1990, Volume: 16, Issue:6

    Topics: Anesthesia; Animals; Anti-Arrhythmia Agents; Benzopyrans; Blood Pressure; Cardiovascular Agents; Coronary Circulation; Coronary Disease; Cromakalim; Decanoic Acids; Diltiazem; Dogs; Female; Glyburide; Heart; Heart Rate; Hydroxy Acids; In Vitro Techniques; L-Lactate Dehydrogenase; Male; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Oxygen Consumption; Potassium Channels; Pyrroles; Rats; Rats, Inbred Strains

1990
Comparative effects of K+ channel blockade on the vasorelaxant activity of cromakalim, pinacidil and nicorandil.
    European journal of pharmacology, 1988, Aug-02, Volume: 152, Issue:3

    Topics: 4-Aminopyridine; Aminopyridines; Animals; Benzopyrans; Cardiovascular Agents; Cromakalim; Guanidines; In Vitro Techniques; Male; Mesenteric Arteries; Muscle Relaxation; Muscle, Smooth, Vascular; Niacinamide; Nicorandil; Pinacidil; Potassium Channels; Procaine; Pyrroles; Rabbits; Rubidium Radioisotopes; Tetraethylammonium Compounds; Vasodilator Agents

1988
Comparison of the cromakalim antagonism and bradycardic actions of a series of novel alinidine analogues in the rat.
    Naunyn-Schmiedeberg's archives of pharmacology, 1994, Volume: 350, Issue:2

    Topics: Animals; Benzopyrans; Cardiovascular Agents; Clonidine; Cromakalim; Heart Rate; In Vitro Techniques; Male; Potassium Channels; Pyrroles; Rats; Structure-Activity Relationship

1994
A bradycardic agent, UL-FS 49, increases atrial force and decreases ventricular force in isolated, perfused heart preparations of dogs.
    The Journal of pharmacology and experimental therapeutics, 1993, Volume: 265, Issue:2

    Topics: Acetylcholine; Adenosine; Animals; Atrial Function; Benzazepines; Benzopyrans; Cardiovascular Agents; Cromakalim; Dogs; Heart Atria; Heart Ventricles; In Vitro Techniques; Myocardial Contraction; Perfusion; Potassium Channels; Pyrroles; Sinoatrial Node; Ventricular Function

1993
Activators of sodium, calcium and potassium channels modulate the cardiac effects of quinidine in vitro.
    Pharmacology & toxicology, 1995, Volume: 77, Issue:5

    Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Azetidines; Benzopyrans; Calcium Channel Agonists; Cardiotonic Agents; Cardiovascular Agents; Cromakalim; Drug Combinations; Guinea Pigs; Heart; Heart Atria; Hemodynamics; In Vitro Techniques; Male; Papillary Muscles; Potassium Channels; Pyrroles; Quinidine; Sodium Channels

1995
Tolbutamide blocks postsynaptic but not presynaptic effects of adenosine on hippocampal CA1 neurones.
    Journal of neural transmission (Vienna, Austria : 1996), 1998, Volume: 105, Issue:2-3

    Topics: Adenosine; Animals; Baclofen; Calcium; Cardiovascular Agents; Cromakalim; Electric Stimulation; GABA Agonists; Hippocampus; Hypoglycemic Agents; Male; Neurons; Potassium Channel Blockers; Potassium Channels; Pyramidal Cells; Rats; Rats, Wistar; Receptors, Presynaptic; Synapses; Tolbutamide

1998
Pharmacologic characterization of BMS-191095, a mitochondrial K(ATP) opener with no peripheral vasodilator or cardiac action potential shortening activity.
    The Journal of pharmacology and experimental therapeutics, 2001, Volume: 297, Issue:3

    Topics: Action Potentials; Animals; Benzopyrans; Cardiovascular Agents; Cromakalim; Decanoic Acids; Dose-Response Relationship, Drug; Glyburide; Guanidines; Guinea Pigs; Heart; Heart Conduction System; Hydroxy Acids; Imidazoles; In Vitro Techniques; Male; Mitochondria; Myocardial Ischemia; Myocardial Reperfusion; Papillary Muscles; Patch-Clamp Techniques; Potassium; Potassium Channels; Rats; Rats, Sprague-Dawley; Vasodilator Agents; Vasomotor System

2001